Ibuprofen Fresenius i.v. 400 mg / 100 ml

Ibuprofen Fresenius i.v. 400 mg / 100 ml is a medicine authorised by Swissmedic under authorisation number 68450. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 December 2021 and the authorisation is valid without a time limit. ATC code M01AE01 places the medicine in the group Anti-inflammatory and antirheumatic products.

  • Dispensing category B
  • Authorisation number 68450
  • ATC M01AE01
  • Synthetic medicines
Authorisation data
Authorisation number68450
NameIbuprofen Fresenius i.v. 400 mg / 100 ml
Full nameIbuprofen Fresenius i.v. 400 mg / 100 ml, Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM01AE01
First authorisation02 December 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ibuprofen Fresenius i.v. 400 mg / 100 ml, InfusionslösungB02 December 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110 x 100mlM01AE0107.10.1.B
240 x 100mlM01AE0107.10.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ibuprofen Fresenius i.v. 400 mg / 100 ml authorised in Switzerland?

Yes. Ibuprofen Fresenius i.v. 400 mg / 100 ml is authorised by Swissmedic under authorisation number 68450, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ibuprofen Fresenius i.v. 400 mg / 100 ml have?

Ibuprofen Fresenius i.v. 400 mg / 100 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ibuprofen Fresenius i.v. 400 mg / 100 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com